// App-Quantinova.ai

1059 : Investigating the Dual Targeting of BCL-2 and CD38 in Models of Acute Myeloid Leukemia

Researchers

Presenter

  • Jayna J Mistry

Principal Investigators

  • Charlotte Hellmich

  • Amelia Lambert

  • Jamie A Moore

  • Aisha Jibril

  • Angela Collins

  • Federica Di Palma

  • Kristian M Bowles

  • Stuart A Rushworth

Medical Centers

  • Norwich Medical School, The University of East Anglia, Attleborough, ENG, United Kingdom

  • University of East Anglia, Norwich, UK

  • The University of East Anglia, Norwich, United Kingdom

  • Norwich Medical School, The University of East Anglia, Attleborough, ENG, United Kingdom

  • Medicine, Norwich Medical School University of East Anglia, Norwich, United Kingdom

  • Ophthalmology, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom

  • Quadram Institute, UK, Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • B-cell lymphoma 2

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Translocator protein

Drug/Treatment

  • daratumumab Intravenous

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved